See also this year's filing and all EDGAR filings for this company.
PDF Report 0000944809_2020_OPKO_Health_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.9376329715361068, 'aggregate_val': 1183047000, 'exp_sum': 610563000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 343305000, 'ResearchAndDevelopmentExpense': 117870000, 'remainder_Expenses': 149388000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.7855733987079463, 'aggregate_val': 1395316000, 'exp_sum': 500908000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 355573000, 'ResearchAndDevelopmentExpense': 75316000, 'remainder_Expenses': 70019000}} |
Graph
Absolute values for 0000944809, OPKO Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 324,045,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,200,902,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 784,325,000 |
| 4 | LiabilitiesCurrent | 249,119,000 |
| 5 | LiabilitiesNoncurrent | 445,394,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 334,979,668 |
| 9 | ResearchAndDevelopmentExpense | 98,407,331 |
| 10 | remainder_Expenses | 719,956,501 |
| 11 | remainder_Revenues | 868,975,529 |
| 12 | remainder_NetIncome | -31,034,210 |
| 13 | remainder_ComprehensiveNetIncome | -9,494,148 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,309,272,000 |
| 1 | Liabilities | 694,513,000 |
| 2 | Expenses | 1,153,343,500 |
| 3 | Revenues | 868,975,529 |
| 4 | StockholdersEquity | 1,614,759,000 |
| 5 | NetIncome | -315,402,181 |
| 6 | ComprehensiveNetIncome | -320,149,255 |
| 7 | BaseVar | 2,533,316,194 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.13 |
| 9 | EconomicCapitalRatio | 3.11 |